Jackson Wealth Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.96M Sell
47,245
-362
-0.8% -$29K 0.31% 62
2025
Q4
$4.54M Buy
47,607
+842
+2% +$82.5K 0.44% 52
2025
Q3
$4.57M Buy
46,765
+1,052
+2% +$109K 0.46% 52
2025
Q2
$4.91M Sell
45,713
-5,248
-10% -$531K 0.53% 46
2025
Q1
$5.14M Sell
50,961
-809
-2% -$81.5K 0.62% 42
2024
Q4
$4.62M Buy
51,770
+47,791
+1,201% +$4.21M 0.52% 49
2024
Q3
$333K Buy
+3,979
New +$314K 0.04% 116

Other funds holding BSX

Jackson Wealth Management's BSX Position: Q1 2026 in Review

Jackson Wealth Management reduced its Boston Scientific (BSX) stake by 0.76% in Q1 2026, selling an estimated $29K and leaving 47,245 shares worth $2.96M. The position accounts for 0.31% of the portfolio, ranked #62.

Jackson Wealth Management first reported a position in BSX in Q3 2024 and has held it in 7 quarters since. The position peaked at $5.14M in Q1 2025. 1,666 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Jackson Wealth Management held 47,245 shares of Boston Scientific worth $2.96M as of Q1 2026.
  • Jackson Wealth Management sold 362 Boston Scientific shares in Q1 2026, an estimated $29K.
  • Boston Scientific made up 0.31% of Jackson Wealth Management's portfolio in Q1 2026, its #62 holding.
  • Jackson Wealth Management first reported a position in Boston Scientific in Q3 2024 and has held it in 7 quarters since.
  • Jackson Wealth Management's Boston Scientific position peaked at $5.14M in Q1 2025.
  • 1,666 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Jackson Wealth Management's 13F filing for Q1 2026, filed 11 May 2026.